Barbara Haller, M.D., PhD
Assistant Professor of Laboratory Medicine
Chief of Microbiology, SFGH
bhaller@itsa.ucsf.edu

Mailing Address:
2M35 Clinical Lab
San Francisco General Hospital
1001 Potrero Avenue
San Francisco, CA 94110

Office Location:
San Francisco General Hospital, 2M35 Clinical Lab, Microbiology Division

Research Interests: Test evaluation in Clinical Microbiology, Immunology and Molecular Diagnostics and Study of Antimicrobial Resistance in Bacteria

Select Publications:

Visosky, A.M., A.H. Murr, V. Ng, T. Dentoni, L. Weir, and B.L. Haller. Multiple-use atomizers in outpatient otolaryngology clinics are not necessarily an infectious risk. Otolaryngology Head Neck Surg. (2003) 128: 447-451.

Pan, E.S., B.A. Diep, H.A. Carleton, E.D. Charlebois, G.F. Sensabaugh, B.L. Haller, and F. Perdreau-Remington. Increasing Prevalence of Methicillin-Resistant Staphylococcus aureus Infection in California Jails. Clin. Inf. Dis. (2003) 37: 1384-1388.

Winston, L.G., S. Pang, B.L. Haller, M. Wong, H.F. Chambers, and F. Perdreau-Remington. API 20 Strep Identification System May Incorrectly Speciate Enterococci with Low Level Resistance to Vancomycin. Diag. Micro. Inf. Dis. (2004) 48: 287-288.

Elbeik, T., N. Markowitz, P. Nassos, U. Kumar, S. Beringer, B. Haller, and V. Ng. Simultaneous Run of the Bayer VERSANT HIV-1 Version 3.0 and HCV bDNA Version 3.0 Quantitative Assays on the System 340: Reliable Quantitation with Improved Work Flow. J. Clin. Micro. (2004) 42: 3120-3127.

Ohm-Smith, M.J., P.S. Nassos, and B.L. Haller. Evaluation of the Binax NOW, BD Directogen, and BD Directogen EZ Assays for Detection of Respiratory Syncytial Virus. J. Clin. Micro. (2004) 42: 2996-2999.

Education and Training:

PhD, Genetics, University of Minnesota, 1983

MD, St. Louis University School of Medicine, 1990

Residency in Clinical Pathology, Washington University School of Medicine, 1990-1994

Relevant Links:

http://labmed.ucsf.edu